Importantly, ChIP assay results revealed that the binding between the EGR1 protein and Gαi2 DNA promoter sequence was significantly increased in HCC tumor tissues of four different primary HCC patients (Patient-1#/-2#/-3#/-4#) (Fig. 7I). The gene discussed is EGR1; the disease is neoplasm.